Search Within

Joachim Yahalom

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (140)
  2. Journal Article (110)
  3. Book Section (17)
  4. Research Letter (5)
  5. Conference Paper (4)
  6. Review (1)
Groups
  1. Department of Medicine (277)
  2. Hematologic Malignancies, Division of (277)
  3. Radiation Oncology, Department of (277)
  4. Survivorship Research (277)
  5. Center for Hematologic Malignancies (243)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Craig Moskowitz (87)
  3. David Straus (82)
  4. Brandon Imber (73)
  5. Ariela Noy (71)
  6. Steven Horwitz (65)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (33)
  4. 2022 (13)
  5. 2021 (14)
  6. 2020 (13)

More Years

Publications
  1. Blood (80)
  2. International Journal of Radiation Oncology, Biology, Physics (31)
  3. Hematological Oncology (24)
  4. Journal of Clinical Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (19)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (88)
  2. Elsevier Inc. (48)
  3. Wiley Blackwell (27)
  4. American Society of Clinical Oncology (19)
  5. Harborside Press (19)
  6. Nature Publishing Group (13)

More Publishers

Results (277)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)
    Meeting Abstract

    Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • H. pylori-independent MALT lymphoma of the stomach: Excellent outcome with radiation alone
    Meeting Abstract

    Yahalom, J.; Portlock, C. S.; Gonzales, M.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 5th ed (2001)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Phase II study of accelerated fractionation involved field radiotherapy (IFRT), total body irradiation (TBI), ifosfamide and continuous infusion etoposide with autologous stem cell transplantation (ASCT) in the treatment of patients with relapsed and primary refractory aggressive non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Kewalramani, T.; Malhotra, S.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save
  • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Hedrick, E. E.; Donnelly, G. B.; Hunte, S.; Priovolos, A. C.; Qin, J.; Lyons, N. C.; Yahalom, J.; Nimer, S. D.; more...
    Blood (2000)

    Fulltext@MSK | Save